Increased gene expression of FOXP1 in patients with autism spectrum disorders

Molecular Autism

Volumn 4, Issue 1, 2013, Pages

  Chien, Wei Hsien ^a   Gau, Susan Shur Fen ^b,c,d   Chen, Chun Houh ^e   Tsai, Wen Che ^c   Wu, Yu Yu ^f   Chen, Po Hsu ^g   Shang, Chi Yung ^b,c   Chen, Chia Hsiang ^b,f  

^a FU JEN CATHOLIC UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^d NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^e INSTITUTE OF STATISTICAL SCIENCE   (Taiwan)

^f CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^g OHIO STATE UNIVERSITY   (United States)

Author keywords

Autism; Expression microarray; FOXP1; Genetics; Lymphoblastoid cell line

Indexed keywords

TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR FOXP1; UNCLASSIFIED DRUG;

ADULT; ARTICLE; AUTISM; CONTROLLED STUDY; GENE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENETIC ASSOCIATION; GENETIC MARKER; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; LYMPHOBLASTOID CELL LINE; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION;

EID: 84879489056     PISSN: None     EISSN: 20402392     Source Type: Journal    
DOI: 10.1186/2040-2392-4-23     Document Type: Article

References (61)

1. America Psychiatric Association, Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) Washington, DC: American Psychiatric Association Press Inc 1994
2. Prevalence of parent-reported diagnosis of autism spectrum disorder among children in the US, 2007. Kogan MD, Blumberg SJ, Schieve LA, Boyle CA, Perrin JM, Ghandour RM, Singh GK, Strickland BB, Trevathan E, van Dyck PC, Pediatrics 2009 124 1395 1403 10.1542/peds.2009-1522 19805460
3. Prevalence of autism spectrum disorders in a total population sample. Kim YS, Leventhal BL, Koh YJ, Fombonne E, Laska E, Lim EC, Cheon KA, Kim SJ, Kim YK, Lee H, Song DH, Grinker RR, Am J Psychiatry 2011 168 904 912 10.1176/appi.ajp.2011.10101532 21558103
4. Links between genetics and pathophysiology in the autism spectrum disorders. Holt R, Monaco AP, EMBO Mol Med 2011 3 438 450 10.1002/emmm.201100157 21805639
5. Genetic basis of autism: is there a way forward? Eapen V, Curr Opin Psychiatry 2011 24 226 236 10.1097/YCO.0b013e328345927e 21460645
6. The conundrums of understanding genetic risks for autism spectrum disorders. State MW, Levitt P, Nat Neurosci 2011 14 1499 1506 10.1038/nn.2924 22037497
7. Parallel human genome analysis: microarray-based expression monitoring of 1000 genes. Schena M, Shalon D, Heller R, Chai A, Brown PO, Davis RW, Proc Natl Acad Sci USA 1996 93 10614 10619 10.1073/pnas.93.20.10614 8855227 (Pubitemid 26333036)
8. Genome-wide expression profiling of schizophrenia using a large combined cohort. Mistry M, Gillis J, Pavlidis P, Mol Psychiatry 2013 18 215 225 10.1038/mp.2011.172 22212594
9. Expression profiling in neuropsychiatric disorders: emphasis on glutamate receptors in bipolar disorder. Ginsberg SD, Hemby SE, Smiley JF, Pharmacol Biochem Behav 2012 100 705 711 10.1016/j.pbb.2011.09.015 22005598
10. Postmortem brain abnormalities of the glutamate neurotransmitter system in autism. Purcell AE, Jeon OH, Zimmerman AW, Blue ME, Pevsner J, Neurology 2001 57 1618 1628 10.1212/WNL.57.9.1618 11706102 (Pubitemid 33055480)
11. Gene expression microarray studies in polygenic psychiatric disorders: applications and data analysis. Konradi C, Brain Res Brain Res Rev 2005 50 142 155 10.1016/j.brainresrev.2005.05.004 15964635 (Pubitemid 41613707)
12. The utility of gene expression in blood cells for diagnosing neuropsychiatric disorders. Woelk CH, Singhania A, Perez-Santiago J, Glatt SJ, Tsuang MT, Int Rev Neurobiol 2011 101 41 63 22050848
13. Imprinted DLK1-DIO3 region of 14q32 defines a schizophrenia-associated miRNA signature in peripheral blood mononuclear cells. Gardiner E, Beveridge NJ, Wu JQ, Carr V, Scott RJ, Tooney PA, Cairns MJ, Mol Psychiatry 2012 17 827 840 10.1038/mp.2011.78 21727898
14. Gene expression analysis in lymphoblasts derived from patients with autism spectrum disorder. Yasuda Y, Hashimoto R, Yamamori H, Ohi K, Fukumoto M, Umeda-Yano S, Mohri I, Ito A, Taniike M, Takeda M, Mol Autism 2011 2 9 10.1186/2040-2392-2-9 21615902
15. A discriminating messenger RNA signature for bipolar disorder formed by an aberrant expression of inflammatory genes in monocytes. Padmos RC, Hillegers MH, Knijff EM, Vonk R, Bouvy A, Staal FJ, de Ridder D, Kupka RW, Nolen WA, Drexhage HA, Arch Gen Psychiatry 2008 65 395 407 10.1001/archpsyc.65.4.395 18391128 (Pubitemid 351519889)
16. Elevated adrenomedullin mRNA in lymphoblastoid cells from schizophrenic patients. Huang CH, Chen ML, Tsai YL, Tsai MT, Chen CH, Neuroreport 2004 15 1443 1446 10.1097/01.wnr.0000132202.69212.79 15194870 (Pubitemid 38925239)
17. Evaluating the comparability of gene expression in blood and brain. Sullivan PF, Fan C, Perou CM, Am J Med Genet B Neuropsychiatr Genet 2006 141B 261 268 10.1002/ajmg.b.30272 16526044
18. Gene expression profiling of lymphoblastoid cell lines from monozygotic twins discordant in severity of autism reveals differential regulation of neurologically relevant genes. Hu VW, Frank BC, Heine S, Lee NH, Quackenbush J, BMC Genomics 2006 7 118 10.1186/1471-2164-7-118 16709250 (Pubitemid 44173077)
19. Genome-wide expression profiling of lymphoblastoid cell lines distinguishes different forms of autism and reveals shared pathways. Nishimura Y, Martin CL, Vazquez-Lopez A, Spence SJ, Alvarez-Retuerto AI, Sigman M, Steindler C, Pellegrini S, Schanen NC, Warren ST, Geschwind DH, Hum Mol Genet 2007 16 1682 1698 10.1093/hmg/ddm116 17519220 (Pubitemid 47241828)
20. Gene expression profiling of lymphoblasts from autistic and nonaffected sib pairs: altered pathways in neuronal development and steroid biosynthesis. Hu VW, Nguyen A, Kim KS, Steinberg ME, Sarachana T, Scully MA, Soldin SJ, Luu T, Lee NH, PLoS One 2009 4 5775 10.1371/journal.pone.0005775 19492049
21. Cellular and mitochondrial glutathione redox imbalance in lymphoblastoid cells derived from children with autism. James SJ, Rose S, Melnyk S, Jernigan S, Blossom S, Pavliv O, Gaylor DW, FASEB J 2009 23 2374 2383 10.1096/fj.08-128926 19307255
22. Feasibility and relevance of examining lymphoblastoid cell lines to study role of microRNAs in autism. Talebizadeh Z, Butler MG, Theodoro MF, Autism Res 2008 1 240 250 10.1002/aur.33 19360674
23. Utilization of lymphoblastoid cell lines as a system for the molecular modeling of autism. Baron CA, Liu SY, Hicks C, Gregg JP, J Autism Dev Disord 2006 36 973 982 10.1007/s10803-006-0134-x 16845580 (Pubitemid 46020352)
24. Autism diagnostic interview-revised: a revised version of a diagnostic interview for caregivers of individuals with possible pervasive developmental disorders. Lord C, Rutter M, Le Couteur A, J Autism Dev Disord 1994 24 659 685 10.1007/BF02172145 7814313 (Pubitemid 24309810)
25. Behavioral problems and parenting style among Taiwanese children with autism and their siblings. Gau SS, Chou MC, Lee JC, Wong CC, Chou WJ, Chen MF, Soong WT, Wu YY, Psychiatry Clin Neurosci 2010 64 70 78 10.1111/j.1440-1819. 2009.02034.x 19968831
26. Association study of the SLC25A12 gene and autism in Han Chinese in Taiwan. Chien WH, Wu YY, Gau SSF, Huang YS, Soong WT, Chiu YN, Chen CH, Prog Neuropsychopharmacol Biol Psychiatry 2010 34 189 192 10.1016/j.pnpbp.2009.11.004 19913066
27. Sex difference in the rates and co-occurring conditions of psychiatric symptoms in incoming college students in Taiwan. Chien Y-L, Gau SS-F, Gadow KD, Compr Psychiatry 2011 52 195 207 10.1016/j.comppsych.2010.03.009 21295227
28. Generalized association plots: information visualization via iteratively generated correlation matrices. Chen CH, Stat Sin 2002 12 7 30
29. GAP: a graphical environment for matrix visualization and cluster analysis. Wu HM, Tien YJ, Chen CH, Comput Stat Data Anal 2010 54 767 778 10.1016/j.csda.2008.09.029
30. Summaries of affymetrix GeneChip probe level data. Irizarry RA, Bolstad BM, Collin F, Cope LM, Hobbs B, Speed TP, Nucleic Acids Res 2003 31 15 10.1093/nar/gng015 12582260
31. Controlling the false discovery rate: a practical and powerful approach to multiple testing. Yoav B, Yosef H, J R Stat Soc Series B Stat Methodol 1995 57 289 300
32. PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Mootha VK, Lindgren CM, Eriksson KF, Subramanian A, Sihag S, Lehar J, Puigserver P, Carlsson E, Ridderstrale M, Laurila E, Houstis N, Daly MJ, Patterson N, Mesirov JP, Golub TR, Tamayo P, Spiegelman B, Lander ES, Hirschhorn JN, Altshuler D, Groop LC, Nat Genet 2003 34 267 273 10.1038/ng1180 12808457 (Pubitemid 36792858)
33. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub TR, Lander ES, Mesirov JP, Proc Natl Acad Sci USA 2005 102 15545 15550 10.1073/pnas.0506580102 16199517 (Pubitemid 41528093)
34. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. da Huang W, Sherman BT, Lempicki RA, Nat Protoc 2009 4 44 57 19131956
35. EMA-A R package for easy microarray data analysis. Servant N, Gravier E, Gestraud P, Laurent C, Paccard C, Biton A, Brito I, Mandel J, Asselain B, Barillot E, Hupé P, BMC research notes 2010 3 277 10.1186/1756-0500-3-277 21047405
36. A forkhead-domain gene is mutated in a severe speech and language disorder. Lai CS, Fisher SE, Hurst JA, Vargha-Khadem F, Monaco AP, Nature 2001 413 519 523 10.1038/35097076 11586359 (Pubitemid 32938749)
37. Genetic advances in the study of speech and language disorders. Newbury DF, Monaco AP, Neuron 2010 68 309 320 10.1016/j.neuron.2010.10.001 20955937
38. Clinically relevant single gene or intragenic deletions encompassing critical neurodevelopmental genes in patients with developmental delay, mental retardation, and/or autism spectrum disorders. Mikhail FM, Lose EJ, Robin NH, Descartes MD, Rutledge KD, Rutledge SL, Korf BR, Carroll AJ, Am J Med Genet A 2011 155A 2386 2396 22031302
39. Multiple domains define the expression and regulatory properties of Foxp1 forkhead transcriptional repressors. Wang B, Lin D, Li C, Tucker P, J Biol Chem 2003 278 24259 24268 10.1074/jbc.M207174200 12692134 (Pubitemid 37548575)
40. Transcriptional and DNA binding activity of the Foxp1/2/4 family is modulated by heterotypic and homotypic protein interactions. Li S, Weidenfeld J, Morrisey EE, Mol Cell Biol 2004 24 809 822 10.1128/MCB.24.2.809-822.2004 14701752 (Pubitemid 38057931)
41. Expression pattern of the winged-helix/forkhead transcription factor Foxp1 in the developing central nervous system. Tamura S, Morikawa Y, Iwanishi H, Hisaoka T, Senba E, Gene Expr Patterns 2003 3 193 197 10.1016/S1567-133X(03) 00003-6 12711548 (Pubitemid 36503669)
42. The FOXP1 winged helix transcription factor is a novel candidate tumor suppressor gene on chromosome 3p. Banham AH, Beasley N, Campo E, Fernandez PL, Fidler C, Gatter K, Jones M, Mason DY, Prime JE, Trougouboff P, Wood K, Cordell JL, Cancer Res 2001 61 8820 8829 11751404 (Pubitemid 34013896)
43. Characterization of Foxp2 and Foxp1 mRNA and protein in the developing and mature brain. Ferland RJ, Cherry TJ, Preware PO, Morrisey EE, Walsh CA, J Comp Neurol 2003 460 266 279 10.1002/cne.10654 12687690 (Pubitemid 36512935)
44. Identification of FOXP1 deletions in three unrelated patients with mental retardation and significant speech and language deficits. Horn D, Kapeller J, Rivera-Brugues N, Moog U, Lorenz-Depiereux B, Eck S, Hempel M, Wagenstaller J, Gawthrope A, Monaco AP, Bonin M, Riess O, Wohlleber E, Illig T, Bezzina CR, Franke A, Spranger S, Villavicencio-Lorini P, Seifert W, Rosenfeld J, Klopocki E, Rappold GA, Strom TM, Hum Mutat 2010 31 1851 E1860 10.1002/humu.21362 20848658
45. De novo mutations in FOXP1 in cases with intellectual disability, autism, and language impairment. Hamdan FF, Daoud H, Rochefort D, Piton A, Gauthier J, Langlois M, Foomani G, Dobrzeniecka S, Krebs MO, Joober R, Lafrenière RG, Lacaille JC, Mottron L, Drapeau P, Beauchamp MH, Phillips MS, Fombonne E, Rouleau GA, Michaud JL, Am J Hum Genet 2010 87 671 678 10.1016/j.ajhg.2010.09. 017 20950788
46. Exome sequencing in sporadic autism spectrum disorders identifies severe de novo mutations. O'Roak BJ, Deriziotis P, Lee C, Vives L, Schwartz JJ, Girirajan S, Karakoc E, Mackenzie AP, Ng SB, Baker C, Rieder MJ, Nickerson DA, Bernier R, Fisher SE, Shendure J, Eichler EE, Nat Genet 2011 43 585 589 10.1038/ng.835 21572417
47. A functional genetic link between distinct developmental language disorders. Vernes SC, Newbury DF, Abrahams BS, Winchester L, Nicod J, Groszer M, Alarcon M, Oliver PL, Davies KE, Geschwind DH, Monaco AP, Fisher SE, N Eng J Med 2008 359 2337 2345 10.1056/NEJMoa0802828
48. Linkage, association, and gene-expression analyses identify CNTNAP2 as an autism-susceptibility gene. Alarcon M, Abrahams BS, Stone JL, Duvall JA, Perederiy JV, Bomar JM, Sebat J, Wigler M, Martin CL, Ledbetter DH, Nelson SF, Cantor RM, Geschwind DH, Am J Hum Genet 2008 82 150 159 10.1016/j.ajhg.2007.09. 005 18179893 (Pubitemid 351726082)
49. A common genetic variant in the neurexin superfamily member CNTNAP2 increases familial risk of autism. Arking DE, Cutler DJ, Brune CW, Teslovich TM, West K, Ikeda M, Rea A, Guy M, Lin S, Cook EH, Chakravarti A, Am J Hum Genet 2008 82 160 164 10.1016/j.ajhg.2007.09.015 18179894 (Pubitemid 351726090)
50. Molecular cytogenetic analysis and resequencing of contactin associated protein-like 2 in autism spectrum disorders. Bakkaloglu B, O'Roak BJ, Louvi A, Gupta AR, Abelson JF, Morgan TM, Chawarska K, Klin A, Ercan-Sencicek AG, Stillman AA, Tanriover G, Abrahams BS, Duvall JA, Robbins EM, Geschwind DH, Biederer T, Gunel M, Lifton RP, State MW, Am J Hum Genet 2008 82 165 173 10.1016/j.ajhg.2007.09.017 18179895 (Pubitemid 351735952)
51. Expanding the clinical spectrum associated with defects in CNTNAP2 and NRXN1. Gregor A, Albrecht B, Bader I, Bijlsma EK, Ekici AB, Engels H, Hackmann K, Horn D, Hoyer J, Klapecki J, Kohlhase J, Maystadt I, Nagl S, Prott E, Tinschert S, Ullmann R, Wohlleber E, Woods G, Reis A, Rauch A, Zweier C, BMC Med Genet 2011 12 106 10.1186/1471-2350-12-106 21827697
52. Forkhead box protein p1 is a transcriptional repressor of immune signaling in the CNS: implications for transcriptional dysregulation in Huntington disease. Tang B, Becanovic K, Desplats PA, Spencer B, Hill AM, Connolly C, Masliah E, Leavitt BR, Thomas EA, Hum Mol Genet 2012 21 3097 3111 10.1093/hmg/dds132 22492998
53. Cntnap2 expression in the cerebellum of Foxp2(R552H) mice, with a mutation related to speech-language disorder. Fujita E, Tanabe Y, Momoi MY, Momoi T, Neurosci Lett 2012 506 277 280 10.1016/j.neulet.2011.11.022 22133810
54. Genetic analysis of genome-wide variation in human gene expression. Morley M, Molony CM, Weber TM, Devlin JL, Ewens KG, Spielman RS, Cheung VG, Nature 2004 430 743 747 10.1038/nature02797 15269782 (Pubitemid 39071339)
55. Methylation mediated silencing of MicroRNA-1 gene and its role in hepatocellular carcinogenesis. Datta J, Kutay H, Nasser MW, Nuovo GJ, Wang B, Majumder S, Liu CG, Volinia S, Croce CM, Schmittgen TD, Cancer Res 2008 68 5049 5058 10.1158/0008-5472.CAN-07-6655 18593903
56. Epigenome-wide ovarian cancer analysis identifies a methylation profile differentiating clear cell histology with epigenetic silencing of HERG K+ channel. Cicek MS, Koestler DC, Fridley BL, Kalli KR, Armasu SM, Larson MC, Wang C, Winham SJ, Vierkant RA, Rider DN, Block MS, Klotzle B, Konecny G, Winterhoff BJ, Hamidi H, Shridhar V, Fan JB, Visscher DW, Olson JE, Hartmann LC, Bibikova M, Chien J, Cunningham JM, Goode EL, Hum Mol Genet 2013 [Epub ahead of print]
57. MicroRNA miR-9 modifies motor neuron columns by a tuning regulation of FoxP1 levels in developing spinal cords. Otaegi G, Pollock A, Hong J, Sun T, J Neurosci 2011 31 809 818 10.1523/JNEUROSCI.4330-10.2011 21248104
58. Modelling schizophrenia using human induced pluripotent stem cells. Brennand KJ, Simone A, Jou J, Gelboin-Burkhart C, Tran N, Sangar S, Li Y, Mu Y, Chen G, Yu D, McCarthy S, Sebat J, Gage FH, Nature 2011 473 221 225 10.1038/nature09915 21490598
59. Induction of human neuronal cells by defined transcription factors. Pang ZP, Yang N, Vierbuchen T, Ostermeier A, Fuentes DR, Yang TQ, Citri A, Sebastiano V, Marro S, Sudhof TC, Wernig M, Nature 2011 476 220 223 21617644
60. Gene expression studies in autism: moving from the genome to the transcriptome and beyond. Voineagu I, Neurobiol Dis 2012 45 69 75 10.1016/j.nbd.2011.07.017 21839838
61. Characteristics and predictive value of blood transcriptome signature in males with autism spectrum disorders. Kong SW, Collins CD, Shimizu-Motohashi Y, Holm IA, Campbell MG, Lee IH, Brewster SJ, Hanson E, Harris HK, Lowe KR, Saada A, Mora A, Madison K, Hundley R, Egan J, McCarthy J, Eran A, Galdzicki M, Rappaport L, Kunkel LM, Kohane IS, PLoS One 2012 7 49475 10.1371/journal.pone. 0049475 23227143